三家主要印度制药公司因质量和混乱问题在美国召回药品。 Three major Indian drug firms recall medicines in the U.S. due to quality and mix-up issues.

印度三家主要制药公司——Sun Pharma、Lupin和Reddy博士——正在回顾由于制造问题和产品混杂在美国的某些药品。 Three major Indian pharmaceutical companies—Sun Pharma, Lupin, and Dr Reddy's—are recalling certain medicines in the US due to manufacturing issues and product mix-ups. Sun Pharma 因溶出度测试失败而召回多动症药物，Lupin 因与 HIV 药物混淆而召回降压药，Dr Reddy's 因污染而召回胃胶囊。 Sun Pharma is recalling ADHD medication due to failing dissolution tests, Lupin is recalling blood pressure drugs due to a mix-up with HIV medication, and Dr Reddy's is recalling stomach capsules due to contamination. 美国FDA将这些产品归类为II类召回产品,表明潜在的暂时健康风险但严重问题的可能性较低. The US FDA classified these as Class II recalls, indicating potential temporary health risks but low chances of serious issues.